The global microbial identification market is expected to enjoy a valuation of USD 3.7 Billion in 2022, and further expand at a CAGR of 11.3% between 2022 and 2032, to reach a valuation of around USD 10.7 Billion by 2032.
Rising demand for microbial identification products across various end-user sectors including pharmaceutical & biotechnology, food & beverage water & environment, diagnostic laboratories, and independent research laboratories is a key factor driving the microbial identification market.
Based on product, the bacterial identification systems segment held the largest market share of about 28.4% in the global microbial identification market in 2021 and it is likely to retain its dominance during the forecast period.
| Attribute | Key Statistics |
|---|---|
| Microbial Identification Market Base Value (2021) | USD 3.3 Billion |
| Estimated Market Value (2022) | USD 3.7 Billion |
| Projected Market Value (2032) | USD 10.7 Billion |
| Value-based CAGR (2022 to 2032) | 11.3% |
| Market Share of Top 5 Countries | 57.9% |
Since the beginning of time, microorganisms such as bacteria, yeasts, and moulds have been crucial to human survival. Similar to how they were in the past, they are closely related to biotechnology, genetic engineering, medicine, and other industries.
They are utilized for their unique properties that allow for the production of food and food-related products, as well as the decomposition of materials such as lignocellulosic biomass as a source of second-generation ethanol or biogas, amino acids, antibiotics, hormones, and other therapeutic compounds.
At the same time, some genetic characteristics and metabolic capacities of bacteria render them hazardous to both industry (food spoiling) and human health. Therefore, identifying the type of microbial organisms becomes extremely crucial. For this purpose, microbial identification products and methods are being increasingly used across various industries. This is providing a strong impetus to the growth of the global microbial identification market.
The overall microbial identification market held a value share of approximately 78.3% of the global rapid microbiology testing market which stood at ~USD 4.2 Billion in 2021.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global sales of microbial identification products are projected to increase at 11.3% CAGR between 2022 and 2032, in comparison to 10.5% CAGR during the historical period from 2017 to 2021.
The rising prevalence of infectious diseases, growing food safety concerns, and increasing adoption of microbial identification products across various end-use sectors including food & beverage, diagnostic laboratories, the pharmaceutical industry, and independent research laboratories are some of the key factors driving the global identification market.
Similarly, advancements in microbiology and continuous new product launches and approvals are anticipated to expand the microbial identification market during the forecast period.
A key trend seen in the microbial identification market globally is a shift in preference toward genotypic identification methods. This is because the genotypic microbial identification method, which is based on nucleic acid analysis, is more accurate and dependable.
When compared to traditional assays, the use of advanced technologies has made the process of microbial identification more precise, faster, and more accurate. These methods are low-cost and have a high throughput time. For example, the MALDI-TOF method is commonly used because it produces faster results, uses few consumables, and is inexpensive.
The increased prevalence of infectious diseases, rising disposable incomes, and government activities are all factors expected to drive the global microbial identification market.
According to MDPI microorganisms in 2019, about 1400 pathogens are thought to be capable of causing human disease. Pathogenic bacteria alone are responsible for 350 million cases of foodborne illness.
Every year, 48 million foodborne infections occur in the USA, resulting in around 128,000 hospitalizations and 3000 fatalities. Poor water hygiene can cause 1.7 million deaths worldwide each year, with children accounting for nine out of ten deaths and underdeveloped countries accounting for nearly all of the deaths.
Campylobacter jejuni, enterotoxigenic Escherichia coli, Aeromonas spp., Shigella spp. and Vibrio cholerae, Clostridium difficile, enterotoxigenic Bacteroides fragilis, and Cryptosporidium parvum are among the microorganisms responsible for these infections and deaths.
Sequencing approaches have had some advantages compared to media-based methods as well as biochemical testing for microbial identification. While biochemical tests and agar media-based methods are used to identify bacteria and fungi, they were not intended to identify viruses, and can only be used for cultural species. Because sequencing can identify viruses as well as unculturable bacteria, it provides a more robust toolkit.
Advancement in Microbial Identification Technologies to Boost Market Over the Next Ten years
The global microbial identification market is set to expand at an impressive CAGR during the forecast period, owing to initiatives by governments to improve the quality of products like food, beverages, water, and pharmaceuticals, advancements in microbial identification systems, and increasing investments in research and development.
In order to produce customized therapy, spatial mass spectrometry (MS) is a powerful method for acquiring ever-more-detailed insights into proteome changes. New types of tumor-specific proteoforms are being discovered thanks to improvements in MS sensitivity.
The rapidly developing sector of proteogenomics, which has the potential to deepen our understanding of tumour development, is created by the overlap of proteomic data with genomic and transcriptome data. Overall, these developments both confirm the critical role MS-based clinical proteomics plays in cancer research and accelerate its transition to becoming a standard part of clinical diagnosis and treatment.
Robotics, microfluidics, and nanotechnology have aided in the quick advancement of innovative processes by mechanising various components of the PCR assay. These modern approaches, in conjunction with computers and computer programs, are used in real-time PCR, DNA microarrays, and DNA chips.
Hand-held PCR assay instruments are being developed. The PCR and reverse transcription-PCR (RT-PCR) techniques have substantially accelerated and improved the accuracy of human and animal disease diagnosis, particularly for infectious agents that are difficult to identify or validate. The PCR method has enabled the genetic characterization of microbiological isolates to be done cheaply and quickly for identification, typing, and epidemiological comparison.
These aforementioned developments are expected to boost the growth of the microbial identification market during the forecast period.
Principal Consultant
The strict regulatory approvals and turnaround time can hamper the market growth of the microbial identification market during the forecast period.
In the clinical laboratory, matrix-assisted laser desorption-ionization time of flight mass spectrometry (MALDI-TOF MS) is replacing older approaches for identifying bacteria. This has resulted in advancements in clinical care, such as better diagnosing infections caused by relatively rare species and shorter time to diagnosis. In many circumstances, this results in a shorter time for suitable therapy and even a shorter period of hospital stay.
This, however, comes with limitations such as inherent commonalities between organisms and a limited amount of spectra in the database, species discrimination, and misidentification can occur. These problems occur on a relatively low frequency and are usually correctable with additional testing.
Inadequate sample size, non-homogeneous distribution of microbes in most dietary matrices and habitats, and the influence of non-random sampling can all lead to inaccurate findings. Furthermore, although microbiological testing results frequently identify outcomes, they do not always show the related sources or controls of contamination.
These factors cumulatively propose a negative effect on the developmental growth of the microbial identification market.
Availability of Advanced Microbial Identification Solutions Driving Market in the USA
The USA is likely to account for the largest market share of around 34.5% in the global microbial identification market in 2022 and further accelerate at a stupendous pace during the next ten years (2022 to 2032).
Growth in the USA microbial identification market is driven by the growing need for improving the quality of food and pharmaceuticals and the availability of advanced testing solutions like the Sherlock Microbial Identification System (MIS).
The Sherlock Microbial Identification System (MIS) was launched in 1991 as a rapid, accurate, and affordable system for identifying over 1,500 microbial species, fatty acids, and PLFAs using GC-FAME analysis, and has since gained increasing recognition from the USA Centers for Disease Control and Prevention (CDC).
It is being acknowledged by the various regulatory bodies for the identification of aerobic bacteria and has received approval from AOAC INTERNATIONAL for the identification of Bacillus anthracis, the anthrax pathogen. The growing popularity of these products for microbial identification will continue to expand the microbial identification market within the country during the forecast period.
Similarly, increasing investments in research and development, the presence of leading manufacturers, and rising government support will push the demand for microbial identification products over the next ten years.
Rising Prevalence of Infectious Diseases Pushing Demand in China
China held approximately 51.3% share in the East Asia microbial identification market in 2021 and is projected to expand at a lucrative CAGR of 10.1% during the forecast period. The increasing prevalence of infectious diseases, growing awareness among people, and increasing government initiatives for addressing food safety concerns are driving the market in China.
Similarly, the growing number of FDA approvals in China, increasing technological advancements, and the large presence of leading manufacturers will boost the market in the country during the next ten years.
Advancements in Microbial Identification Products and Methods to Boost Market in Germany
As per FMI, the microbial identification market in Germany is set to exhibit a CAGR of nearly 9.3% during the forecast period, making it one of the leading markets across Europe.
The pharmaceutical industry's intense focus on research operations to develop innovative therapies and vaccines will support the expansion of the microbial identification market in Germany during the projected period.
Similarly, the continuous introduction of new microbial identification products by leading players like Bruker is likely to play a key role in expanding the market across Germany. For instance, Bruker introduced new products and methods for the leading MALDI Biotyper® (MBT) platform at the 31st European Congress of Clinical Microbiology & Infectious Diseases in July 2021.
With recent advancements in microbial identification methods, the country is set to propel the global sales of the microbial identification market over the forecasted years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Bacterial identification Systems Remain the Highly-Sought After Product in the Market
The bacterial identification systems segment held a market share of about 28.4% in the global market in 2021 and it is expected to grow at a CAGR of 13.8% during the forecast period. This can be attributed to the rising adoption of bacterial identification systems across various end-use sectors.
Quick and precise detection of pathogenic microorganisms isolated from food samples is critical for both food quality assurance and tracing bacterial pathogen outbreaks within the food chain. Automated microbial identification technologies are becoming increasingly used in clinical and food microbiology laboratories. These systems have several significant advantages over traditional approaches, including reduced labour, reduced human error, higher sample throughput, and faster test result turnaround times.
Phenotypic Methods are Mostly Employed by End Users
The phenotypic methods segment held a revenue share of 58.7% in the global microbial identification market in 2021 and it is expected to grow at an impressive growth rate during the forecast period. This can be attributed to the rising usage of phenotypic methods for microbial identification purposes.
Phenotypic methods use expressed gene products to distinguish among different microorganisms. These methods provide essential information that enables microbiologists to make informed decisions regarding product risk and recognize changes in environmental microflora.
Phenotypic microbial identification methods are mostly used in clinical, food, water, and pharmaceutical microbiological testing laboratories.
The usage of Microbial Identification Products Remain High for Diagnostic Applications
The diagnostic application segment held the highest market share value of 32.5% in the microbial identification market in 2021 and it is likely to retain its dominance during the assessment period. The increasing prevalence of acute and chronic infections and food-borne diseases is a key factor encouraging the adoption of microbial identification products and methods for diagnostic purposes.
The pharmaceutical and Biotechnology Industry Witnessing the Highest Demand for Microbial Identification
As per FMI, the pharmaceutical and biotechnology industry holds the highest market share value of 24.4% in 2021 and it is poised to expand at a strong pace during the assessment period. Increasing research and developmental activities and product innovations by pharmaceutical manufacturers are propelling sales of the overall microbial identification market.
With several competitors in the microbial identification production sphere, the overall market is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.
Instances of key developmental strategies by the industry players in the microbial identification market are given below:
| Attribute | Details |
|---|---|
| Estimated Market Size (2022) | USD 3.7 Billion |
| Projected Market Size (2032) | USD 10.7 Billion |
| Anticipated Market Size (2022 to 2032) | 11.3% |
| Forecast Period | 2017 to 2021 |
| Historical Data Available for | 2022 to 2032 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC Countries, South Africa, and North Africa |
| Key Market Segments Covered | Product, Method, Application, End User, and Region |
| Key Companies Profiled | Danaher Corporation; Bruker Corporation; Thermo Fisher Scientific; Siemens Healthineers; Shimadzu Corporation; QIAGEN N.V; bioMerieux S.A.,; Merck & Co Inc.,; Biolog, Inc.,; Becton, Dickinson, and Company; Beckman Coulter; Wickham Laboratories; VWR International, LLC.; MIDI Inc.,; Siemens Healthcare; Charles River Laboratories Inc |
The global microbial identification market size reached USD 3.3 Billion in 2021 and is likely to touch a valuation of USD 3.7 Billion by 2032.
The microbial identification market is expected to reach USD 10.7 Billion by the end of 2032, with overall sales growing at 11.3% CAGR throughout the forecast period.
High prevalence of infectious and food-borne diseases, novel product development, and increasing prevalence of antimicrobial resistance cases, are some of the key trends in this market.
The USA, India, China, Germany, and Japan are expected to drive demand for the microbial identification products.
The USA accounted for about 88.9% of the North American microbial identification market in 2021.
Demand for microbial identification in Europe is expected to grow at 11.0% CAGR over the next ten years.
The overall microbial identification market in Latin America is anticipated to expand at 10.7% CAGR during the forecast period.
The MEA microbial identification market is expected to register a growth of 8.8% over the next ten years.
China, the USA, and Germany are the key producers of microbial identification products.
Danaher Corporation, Bruker Corporation, Thermo Fisher Scientific, Siemens Healthineers, Shimadzu Corporation, QIAGEN N.V, bioMerieux S.A., Merck & Co Inc., Biolog, Inc., Becton, Dickinson and Company, Beckman Coulter, Wickham Laboratories, VWR International, LLC., MIDI Inc., Siemens Healthcare, and Charles River Laboratories Inc. are some of the key players in the microbial identification market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Key Success Factors 5. Market Background 7. Global Market Volume (Units) Analysis 2017 to 2021 and Forecast, 2022 to 2032 8. Global Market - Pricing Analysis 9. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2021 and Forecast, 2022 to 2032 10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Product 10.1. Bacterial Identification Systems 10.2. Microbial Enumeration Systems 10.3. Bacterial Resistance Identification Systems 10.4. Microbiology Analyzers 10.5. Parasitology Analyzers 11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Methods 11.1. Phenotypic methods 11.2. Proteotypic Methods 11.3. Genotypic methods 12. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Application 12.1. Diagnostic Application 12.2. Environmental Application 12.3. Food and Beverages Testing 12.4. Pharmaceutical Application 12.5. Others 13. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by End User 13.1. Pharmaceutical and Biotechnology Industry 13.2. Food and Beverage Industry 13.3. Water and Environment Industry 13.4. Independent Research Laboratories 13.5. Diagnostic Laboratories 13.6. Hospitals 13.7. Others 14. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, by Region 14.1. North America 14.2. Latin America 14.3. Europe 14.4. East Asia 14.5. South Asia 14.6. Oceania 14.7. Middle East and Africa (MEA) 15. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 16. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032 17. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032 18. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 19. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032 20. Oceania Market 2017 to 2021 and Forecast 2022 to 2032 21. Middle East and Africa (MEA) Market Analysis 2017 to 2021 and Forecast 2022 to 2032 22. Market Structure Analysis 23. Competition Analysis 23.1. Danaher Corporation 23.2. Bruker Corporation 23.3. Thermo Fisher Scientific 23.4. Siemens Healthineers 23.5. Shimadzu Corporation 23.6. QIAGEN N.V 23.7. bioMerieux S.A. 23.8. Merck & Co Inc. 23.9. Biolog, Inc. 23.10. Becton, Dickinson, and Company 23.11. Beckman Coulter 23.12. Wickham Laboratories 23.13. VWR International, LLC. 23.14. MIDI Inc. 23.15. Siemens Healthcare 23.16. Charles River Laboratories Inc. 24. Assumptions and Acronyms Used 25. Research Methodology
Explore Healthcare Insights
View Reports
Microbial Identification Market
